Physician profile
Ian Armstrong
NPI 1851300859
$2,420.59
in general payments reported to CMS, 2019-2025
9 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $217 · 2022: $441 · 2023: $45.02 · 2024: $68.94 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437 · Travel and Lodging: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.95 |
| Travel and Lodging | $185.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clariance, INC. | $900.00 | 2019 | |
| Medtronic, INC. | $486.08 | 2022-2023 | O-Arm |
| Orthofix Medical, INC. | $425.36 | 2025 | Lattus |
| Alphatec Spine, INC | $216.77 | 2020 | |
| Medtronic USA, INC. | $191.15 | 2019 | |
| Bard Peripheral Vascular, INC. | $83.19 | 2025 | Rotarexs 6 F X 135 Cm |
| Boston Scientific Corporation | $68.94 | 2024 | Ranger |
| Nuvasive, INC. | $49.10 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.